Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The biotech company from Montpellier continues its rebound at midday in a well-oriented Parisian market. The stock moves away from its moving averages…
Medincell announced on Tuesday that its management will participate in two major American biotech conferences in June. These presentations come as the…
The European Medicines Agency has accepted the marketing authorization application for Olanzapine LAI, a long-acting subcutaneous injection of olanzap…
The Montpellier-based biotech's stock falls 2.23% to €26.34 at midday in a declining Paris market. The SBF 120 is down 0.44% and the CAC 40 loses 0.49…
The biotech company from Montpellier gains 4% to €27.06 by midday, ranking among the top risers on the SBF 120. The stock is nearing its resistance at…
The Montpellier-based biotech's stock fell by 2.78% to €26.62 at mid-session, in a Paris market weighed down by soaring long-term rates and a surge in…
The Montpellier-based biotech's stock fell 2.02% to €28.14 at midday in a sluggish Paris market. The SBF 120 is down 1.36% in session and the CAC 40 h…
The Montpellier-based biotech's stock picks up pace mid-session, on the eve of a highly anticipated meeting with analysts. At €26.86, the stock is up …
The biotech company from Montpellier opens the trading session on Wednesday, May 6, 2026, with a strong acceleration. The MedInCell stock climbs 4.23%…
The Montpellier-based biotech regains momentum in the mid-afternoon, following the CAC 40 which is up by 0.49% during the session. The stock is approa…
